Men, X., Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Reynolds, C. F., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2024). CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression. Clinical Pharmacology & Therapeutics, 115(5), 1065–1074. Portico. https://doi.org/10.1002/cpt.3162
Columbia Affiliation:
Subjects:
Cyclohexanols
(MeSH)
Cytochrome P-450 CYP2D6
(MeSH)
Molecular Mechanisms of Depression Treatment Strategies
(OpenAlex Topic)
Drug Metabolism and Pharmacogenomics
(OpenAlex Topic)
Network Analysis of Psychopathology and Mental Disorders
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1002/cpt.3162
PMID:
DOI:
Publication Date:
Data Source:
OpenAlex